These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 1663720

  • 1. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, Dema A, Kotsovoulou V, Pavlidis N.
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [Abstract] [Full Text] [Related]

  • 2. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [Abstract] [Full Text] [Related]

  • 3. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E, Chondros K, Kouvaris J, Kakari S, Papavassiliou K.
    Anticancer Res; 1992 Feb; 12(1):251-5. PubMed ID: 1567173
    [Abstract] [Full Text] [Related]

  • 4. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
    Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A.
    Cancer Detect Prev; 1994 Dec; 18(3):209-20. PubMed ID: 8076383
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C, Mohn-Staudner A, Vetter H, Kokron O, Baumgartner G, Scheiner W, Zwick H, Koderhold G, Alth G, Dudczak R.
    Wien Klin Wochenschr; 1996 Dec; 108(15):467-72. PubMed ID: 8806188
    [Abstract] [Full Text] [Related]

  • 7. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J, Philipp M, Velcovsky HG, Morr H, Katz N.
    Anticancer Res; 2003 Dec; 23(2A):885-93. PubMed ID: 12820318
    [Abstract] [Full Text] [Related]

  • 8. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR, Zhang X, Xu ZF, Zheng S.
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [Abstract] [Full Text] [Related]

  • 9. Significance of serum sialoglycoproteins in patients with lung cancer.
    Patel PS, Baxi BR, Balar DB.
    Neoplasma; 1989 Feb; 36(1):53-9. PubMed ID: 2539569
    [Abstract] [Full Text] [Related]

  • 10. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M, Furuse K, Arai R, Tsuruta M, Kodama N, Hayashi S, Kiyota M, Kubota K, Mori T, Yamamoto S.
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M, Chondros K, Ferderigos AS, Daganou M, Dema A, Dalamaga A, Kakari S, Stringou E.
    Anticancer Res; 1992 Jan; 12(4):1267-70. PubMed ID: 1503419
    [Abstract] [Full Text] [Related]

  • 12. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM, Sauer-Eppel H, Bruzdziak TH.
    Anticancer Res; 2007 Jan; 27(4A):1911-5. PubMed ID: 17649794
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)].
    Flaschka G, Marth E, Desoye G, Freidl W, Walzl M.
    Zentralbl Neurochir; 1990 Jan; 51(3):129-37. PubMed ID: 2092546
    [Abstract] [Full Text] [Related]

  • 14. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, Uslu SS.
    Kulak Burun Bogaz Ihtis Derg; 2004 Jan; 12(1-2):23-30. PubMed ID: 16010093
    [Abstract] [Full Text] [Related]

  • 15. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS, Raval GN, Rawal RM, Patel GH, Balar DB, Shah PM, Patel DD.
    Neoplasma; 1995 Jan; 42(5):271-4. PubMed ID: 8552208
    [Abstract] [Full Text] [Related]

  • 16. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
    Wu Y, Wu Y, Wang L, Qu L.
    Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
    [Abstract] [Full Text] [Related]

  • 17. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K.
    Anticancer Res; 1999 Jul; 19(4A):2673-8. PubMed ID: 10470218
    [Abstract] [Full Text] [Related]

  • 18. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R, Auge JM, Filella X, Viñolas N, Alicarte J, Domingo JM, Ballesta AM.
    Anticancer Res; 2005 Jul; 25(3A):1773-8. PubMed ID: 16033098
    [Abstract] [Full Text] [Related]

  • 19. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
    De Angelis G, De Marinis F, Bigioni D, Migliorino MR, Alma MG, Pigorini F.
    J Nucl Med Allied Sci; 1990 Jul; 34(4 Suppl):135-40. PubMed ID: 1965445
    [No Abstract] [Full Text] [Related]

  • 20. [Level of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of small cell lung cancer patients: correlation with performance status, disease extent and prognosis].
    Szturmowicz M, Rogińska E, Roszkowski K, Kwiek S, Filipecki S, Rowińska-Zakrzewska E.
    Pneumonol Alergol Pol; 1993 Jul; 61(9-10):467-73. PubMed ID: 8111322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.